Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1321 AL 1335

Pacemaker and Defibrillator Implantation and Programming in Patients with Deep Brain Stimulation

Elliott M, Momin S, Fiddes B, Farooqi F, Sohaib SA.

Arrhythm Electrophysiol Rev. 2019 May;8(2):138-142. doi: 10.15420/aer.2018.63.2.

Using wearables to assess bradykinesia and rigidity in patients with Parkinson's disease: a focused, narrative review of the literature

Teshuva I, Hillel I, Gazit E, Giladi N, Mirelman A, Hausdorff JM.

J Neural Transm (Vienna). 2019 Jun;126(6):699-710. doi: 10.1007/s00702-019-02017-9. Epub 2019 May 22.

The effect of Tai Chi and Qigong on health-related quality of life in Parkinson's disease: a systematic review and meta-analysis of systematic reviews

Fidan O, Seyyar GK, Aras B, Colak E, Aras O.

Int J Rehabil Res. 2019 Sep;42(3):196-204. doi: 10.1097/MRR.0000000000000358.

Anxiety disorders and medical illness comorbidity and treatment implications

Latas M, Vučinić Latas D, Spasić Stojaković M.

Curr Opin Psychiatry. 2019 Sep;32(5):429-434. doi: 10.1097/YCO.0000000000000527.

An association between bipolar disorder and Parkinson disease: When mood makes you move

Pontone GM, Koch G.

Neurology. 2019 Jun 11;92(24):1125-1126. doi: 10.1212/WNL.0000000000007641. Epub 2019 May 22.

Role of nurses and nurse practitioners in the recognition, diagnosis, and management of neurogenic orthostatic hypotension: a narrative review

Biswas D, Karabin B, Turner D.

Int J Gen Med. 2019 May 1;12:173-184. doi: 10.2147/IJGM.S170655. eCollection 2019.

Diverse Pharmacological Activities and Potential Medicinal Benefits of Geniposide

Zhou YX, Zhang RQ, Rahman K, Cao ZX, Zhang H, Peng C.

Evid Based Complement Alternat Med. 2019 Apr 16;2019:4925682. doi: 10.1155/2019/4925682. eCollection 2019.

DNAJC proteins and pathways to parkinsonism

Roosen DA, Blauwendraat C, Cookson MR, Lewis PA.

FEBS J. 2019 Aug;286(16):3080-3094. doi: 10.1111/febs.14936. Epub 2019 Jun 20.

Drug treatment strategies for depression in Parkinson disease

Ryan M, Eatmon CV, Slevin JT.

Expert Opin Pharmacother. 2019 Aug;20(11):1351-1363. doi: 10.1080/14656566.2019.1612877. Epub 2019 May 23.

Telomeres in neurological disorders

Anitha A, Thanseem I, Vasu MM, Viswambharan V, Poovathinal SA.

Adv Clin Chem. 2019;90:81-132. doi: 10.1016/bs.acc.2019.01.003. Epub 2019 Feb 21.

Aquaporin 4: A key player in Parkinson's disease

Tamtaji OR, Behnam M, Pourattar MA, Jafarpour H, Asemi Z.

J Cell Physiol. 2019 Dec;234(12):21471-21478. doi: 10.1002/jcp.28871. Epub 2019 May 24.

Overlap Between Frontotemporal Dementia and Dementia with Lewy Bodies: A Treviso Dementia (TREDEM) Registry Case Report

Gallucci M, Dell'Acqua C, Boccaletto F, Fenoglio C, Galimberti D, Di Battista ME.

J Alzheimers Dis. 2019;69(3):839-847. doi: 10.3233/JAD-181298.

Regional gray matter reductions associated with mild cognitive impairment in Parkinson's disease: A meta-analysis of voxel-based morphometry studies

Zheng D, Chen C, Song W, Yi Z, Zhao P, Zhong J, Dai Z, Shi H, Pan P.

Behav Brain Res. 2019 Oct 3;371:111973. doi: 10.1016/j.bbr.2019.111973. Epub 2019 May 22.

Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium

Guttuso T Jr, Andrzejewski KL, Lichter DG, Andersen JK.

J Neurol Sci. 2019 Jul 15;402:121-130. doi: 10.1016/j.jns.2019.05.016. Epub 2019 May 15.

Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)

Peball M, Werkmann M, Ellmerer P, Stolz R, Valent D, Knaus HG, Ulmer H, Djamshidian A, Poewe W, Seppi K.

J Neural Transm (Vienna). 2019 Aug;126(8):1061-1072. doi: 10.1007/s00702-019-02021-z. Epub 2019 May 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias